Drug discovery still too often relies on expensive trial and error. Researchers from ICTER show there is another way—building ...

A multicolored 3D model of an enzyme binding double-stranded DNA against a light purple background Computational enzyme design could allow for reactions not seen in nature. Credit: Ian Haydon ...

Using bright X-rays from the Department of Energy's SLAC National Accelerator Laboratory and Lawrence Berkeley National ...

Traditional drug discovery often screens vast chemical libraries, a process that is costly, slow, and prone to producing molecules that hit multiple targets. By starting with tiny molecular fragments ...

Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.